Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025)

Starting soon

Conditions studied: Leprosy, Hansen's Disease, Leprosy--Patients, Lepromatous Leprosy, Leprosy, Multibacillary, Leprosy Neuropathy

In brief

The goal of this observational retrospective study is to characterize the epidemiologic, clinical, diagnostic, and therapeutic features of Hansen's disease cases in Costa Rica between 2018 and 2025. The main questions it aims to answer are: What are the epidemiologic and clinical characteristics of confirmed Hansen's disease cases in Costa Rica? What diagnostic methods, treatments, complications, and outcomes are observed in routine care? All confirmed Hansen's disease cases recorded in national surveillance and with available clinical records during 2018-2025 will be included. Data will be obtained from electronic health records and Ministry of Health reports without participant contact.

Key facts

Study ID

NCT07448389

Run by

Caja Costarricense de Seguro Social

People needed

130

Starts

2026-05-01

Expected to finish

2026-12-01

Last updated by the study team

2026-03-09

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of Hansen's disease.
• Diagnosis between 1 January 2018 and 31 December 2025.
• Any age or sex.
• Available digital clinical record.
• Case reported in national surveillance (VE-01).
• Diagnosed or treated in Costa Rican public health institutions.

You may not qualify if…

• Cases whose diagnosis was reviewed and reclassified as another disease.

Where it is running

• Caja Costarricense del Seguro Social — San José, Provincia de San José, Costa Rica

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.